Oligoprogression with Non-EGFR Mutations – 2022 Program: Targeted Therapies Forum

Targeted Therapies Forum 2022: In this video Drs. Aakash Desai and Narjust Florez, discuss how she approaches oligoprogression with mutations other than EGFR.

We thank our sponsors for this year’s support! #Novartis #Janssen #Blueprintmedicine #TakedaOncology #Astrazeneca #LillyOncology #genentech

For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.